Arnuity Ellipta FDA Approved Drugs
ARNUITY ELLIPTA [Fluticasone FuroateC27H29F3O6S]
0.1mg/inh (inhalation powder)
0.2mg/inh (inhalation powder)
GlaxosmithklineAug 20, 2014
- Indicated for the once-daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years of age and older.
FLONASE SENSIMIST ALLERGY RELIEF [Fluticasone FuroateC27H29F3O6S]
0.0275mg/spray (nasal spray, metered)
Glaxosmithkline ConsAug 2, 2016
- Otc use: allergy symptom reliever; temporarily relieves these symptoms due to hay fever or other upper respiratory allergies; nasal congestion, runny nose, sneezing, itchy nose, and (itchy water eyes (ages 12 and up)).
- The treatment of the symptoms of seasonal and perennial allergic rhinitis in patients 2 years of age and older.
- Treatment of rhinitis comprising the nasal application of a pharmaceutical formulation as claimed in us patent 7541350.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.